SEC Form 4 · accession 0001102624-15-000061
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Jan 15, 2015
Accepted (ET)
Jan 16, 2015 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2015 | P | 500 | $0.5999 | A | 7,540,485 | D | |
| Common Stock | Jan 16, 2015 | P | 500 | $0.5999 | A | 7,540,985 | D |
Table II — derivative securities
No Table II lines on this filing.